Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease

Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With... ORIGINAL INVESTIGATION Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease Michael D. Murray, PharmD, MPH; Mary E. Ritchey, RN, MSPH; Jingwei Wu, MS; Wanzhu Tu, PhD Background: Adverse drug events and medication er- spectively, at 12 months. Compared with the control rors are threats to quality care. Inpatient studies suggest group, the risk of any event was 34% lower in the inter- that a pharmacist may reduce these events, but outpa- vention group (risk ratio, 0.66; 95% confidence interval tient studies have not been forthcoming. [CI], 0.50-0.88), including a lower risk of adverse drug events (risk ratio, 0.65; 95% CI, 0.47-0.90), preventable Methods: We conducted a pooled analysis of 2 random- adverse drug events (risk ratio, 0.52; 95% CI, 0.25- ized controlled trials to determine the effect of pharma- 1.09), potential adverse drug events (risk ratio, 0.70; 95% cist intervention on adverse drug events and medication CI, 0.40-1.22), and medication errors (risk ratio, 0.63; errors. We studied 800 outpatient cases of hypertension 95% CI, 0.40-0.98). stratified into complicated (n = 535) and uncomplicated (n = 265). Patients in the complicated stratum had heart Conclusions: This post hoc analysis suggests that phar- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease

Loading next page...
 
/lp/american-medical-association/effect-of-a-pharmacist-on-adverse-drug-events-and-medication-errors-in-080P0jt1AV

References (44)

Publisher
American Medical Association
Copyright
Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinternmed.2009.59
pmid
19398687
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease Michael D. Murray, PharmD, MPH; Mary E. Ritchey, RN, MSPH; Jingwei Wu, MS; Wanzhu Tu, PhD Background: Adverse drug events and medication er- spectively, at 12 months. Compared with the control rors are threats to quality care. Inpatient studies suggest group, the risk of any event was 34% lower in the inter- that a pharmacist may reduce these events, but outpa- vention group (risk ratio, 0.66; 95% confidence interval tient studies have not been forthcoming. [CI], 0.50-0.88), including a lower risk of adverse drug events (risk ratio, 0.65; 95% CI, 0.47-0.90), preventable Methods: We conducted a pooled analysis of 2 random- adverse drug events (risk ratio, 0.52; 95% CI, 0.25- ized controlled trials to determine the effect of pharma- 1.09), potential adverse drug events (risk ratio, 0.70; 95% cist intervention on adverse drug events and medication CI, 0.40-1.22), and medication errors (risk ratio, 0.63; errors. We studied 800 outpatient cases of hypertension 95% CI, 0.40-0.98). stratified into complicated (n = 535) and uncomplicated (n = 265). Patients in the complicated stratum had heart Conclusions: This post hoc analysis suggests that phar-

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Apr 27, 2009

There are no references for this article.